These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10500955)

  • 1. [Risk factor of liver disorders caused by flutamide--statistical analysis using multivariate logistic regression analysis].
    Wada T; Ueda M; Abe K; Kobari T; Yamazaki H; Nakata J; Ikemoto I; Ohishi Y; Aizawa Y
    Hinyokika Kiyo; 1999 Aug; 45(8):521-6. PubMed ID: 10500955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
    Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
    Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flutamide-induced hepatic disorder and serum concentrations of flutamide and its metabolites in patients with prostate cancer].
    Nakagawa Y; Koyama M; Matsumoto M
    Hinyokika Kiyo; 1999 Dec; 45(12):821-6. PubMed ID: 10659414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
    Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
    Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females.
    Bruni V; Peruzzi E; Dei M; Nannini S; Seravalli V; Sisti G; Fambrini M
    Fertil Steril; 2012 Oct; 98(4):1047-52. PubMed ID: 22795685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of treatment with low-dose flutamide in maximum androgen blockade therapy].
    Shimizu K; Kiyohara H; Nakayama J; Fujii T; Hosomi M
    Hinyokika Kiyo; 2001 Apr; 47(4):251-5. PubMed ID: 11411099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatoxicity caused by flutamide increased by hypotensive situation?].
    Serrano Hernández N; García López F; Fedriani Gorria J
    An Med Interna; 1996 Nov; 13(11):552-4. PubMed ID: 9019217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer.
    Ozono S; Yamaguchi A; Mochizuki H; Kawakami T; Fujimoto K; Otani T; Yoshida K; Ichinei M; Yamashita T; Hirao Y
    Prostate Cancer Prostatic Dis; 2002; 5(2):128-31. PubMed ID: 12497002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flutamide-associated acute liver failure.
    Famularo G; De Simone C; Minisola G; Nicotra GC
    Ann Ital Med Int; 2003; 18(4):250-3. PubMed ID: 14971714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fulminant hepatitis associated with treatment with flutamide].
    García-Gascó P; Morata Aldea C; Segura Huertas A; Aparicio Urtasun J
    Med Clin (Barc); 1997 Dec; 109(20):820. PubMed ID: 9493166
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
    Pu YS; Liu CM; Kao JH; Chen J; Lai MK
    Eur Urol; 1999 Oct; 36(4):293-7. PubMed ID: 10473987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
    Kraus I; Vitezic D; Oguic R
    Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide-induced acute hepatitis: investigation on the role of immunoallergic mechanisms.
    Pontiroli L; Sartori M; Pittau S; Morelli S; Boldorini R; Albano E
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):310-4. PubMed ID: 9759603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.
    Nakano K; Ando H; Kurokawa S; Hosohata K; Ushijima K; Takada M; Tateishi M; Yonezawa A; Masuda S; Matsubara K; Inui K; Morita T; Fujimura A
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1191-7. PubMed ID: 25862351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver failure caused by flutamide].
    Guzmán Martínez-Valls PL; Ferrero Doria R; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Gil Franco J; Fontana Compiano LO
    Actas Urol Esp; 1997 Mar; 21(3):278-82. PubMed ID: 9324896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
    Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
    Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic hepatitis after flutamide treatment].
    Bengoechea Gallastegui L; Vita Garay A; Castiella Eguzkiza A; Egido Arroyo JF
    Aten Primaria; 2005 Jun; 36(2):112. PubMed ID: 15989835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of flutamide-induced acute cholestatic hepatitis--a case report.
    Lee HW; Chung JP; Lee KS; Kim KC; Lee KS; Chon CY; Park IS; Kim HG
    Yonsei Med J; 1996 Jun; 37(3):225-9. PubMed ID: 8826789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.